Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1alpha prolyl hydroxylase-2 inhibitors

Bioorg Med Chem Lett. 2008 Sep 15;18(18):5023-6. doi: 10.1016/j.bmcl.2008.08.012. Epub 2008 Aug 9.

Abstract

We report the structure-based design and synthesis of a novel series of aza-benzimidazoles as PHD2 inhibitors. These efforts resulted in compound 22, which displayed highly potent inhibition of PHD2 function in vitro.

MeSH terms

  • Aza Compounds / chemical synthesis*
  • Aza Compounds / chemistry
  • Aza Compounds / pharmacology*
  • Basic Helix-Loop-Helix Transcription Factors
  • Benzimidazoles / chemical synthesis*
  • Benzimidazoles / chemistry
  • Benzimidazoles / pharmacology*
  • Combinatorial Chemistry Techniques
  • Crystallography, X-Ray
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / antagonists & inhibitors*
  • Hypoxia-Inducible Factor-Proline Dioxygenases
  • Models, Molecular
  • Molecular Structure
  • Procollagen-Proline Dioxygenase / antagonists & inhibitors*
  • Structure-Activity Relationship

Substances

  • Aza Compounds
  • Basic Helix-Loop-Helix Transcription Factors
  • Benzimidazoles
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • endothelial PAS domain-containing protein 1
  • EGLN1 protein, human
  • Procollagen-Proline Dioxygenase
  • Hypoxia-Inducible Factor-Proline Dioxygenases